Improving Outpatient Comprehensive Atrial Fibrillation Care Across Central North Carolina Through Direct Primary Care and Patient Engagement
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 70
- 试验地点
- 6
- 主要终点
- Change in Number of Patients Prescribed Appropriate Anticoagulation
研究概览
简要总结
The goal of this study is to determine the effectiveness of a direct-to-provider virtual education program ("AF and EKG Interpretation Project ECHO") for primary care providers who manage patients with atrial fibrillation (AF). The main questions this study aims to answer are:
- Will participants have improvement in knowledge and confidence in managing patients with atrial fibrillation after program completion?
- Will quality and performance metrics improve at the patient level for program participants?
Participants will be asked to:
- Participate in 12 hours of virtual education sessions over twelve weeks via Zoom.
- Complete a knowledge and confidence assessment online before the program starts and after its completion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Primary care provider (Physician, Nurse Practitioner, Physician Assistant) with primary practice in the state of North Carolina
- •Care for adult population
排除标准
- 未提供
研究组 & 干预措施
AF and EKG Interpretation Project ECHO
All recruited participants participate in the AF and EKG Interpretation Project ECHO educational intervention.
干预措施: AF and EKG Interpretation Project ECHO (Other)
结局指标
主要结局
Change in Number of Patients Prescribed Appropriate Anticoagulation
时间窗: 1-year prior to intervention session 1 and 1-year post intervention session 12
This outcome measures the number of patients prescribed appropriate anticoagulation medication based on risk factors for stroke including congestive heart failure (C), hypertension (H), Age \>74 (A2), Diabetes (D), prior stroke or transient ischemic attack (TIA) (S2), vascular disease (V), age 65-74 (A), female sex (Sc), commonly referred to as CHA2DS2-VASc stroke risk score for patients with atrial fibrillation. CHA2DS2-VASc score includes 7 indicators of stroke risk (age (\<65=0, 65-74=1, 75+= 2), sex (male=0, female=1), heart failure (no=0, yes=1), hypertension (no=0, yes=1), prior stroke/TIA (no=0, yes=2), history of vascular disease (no=0, yes=1), and diabetes (no=0, yes=1). Anticoagulation is indicated for a female with a score 3 or higher and males with a score of 2 or higher. This information will be collected from electronic health records of patients cared for by providers who participated in the program.
次要结局
- Change in Number of Patients with Blood Pressure at Goal(1-year prior to intervention session 1 and 1-year post intervention session 12)
- Change in Number of Emergency Department Visits or Hospitalizations for AF or Stroke(1-year prior to intervention session 1 and 1-year post intervention session 12)
- Change in Provider Confidence Level(Baseline and 12 weeks post intervention session 12)
- Change in Number of Patients Prescribed Appropriate Antiplatelet Therapy(1-year prior to intervention session 1 and 1-year post intervention session 12)
- Change in Number of Patients with Heart Rate at Target(1-year prior to intervention session 1 and 1-year post intervention session 12)
- Change Score on Provider Knowledge Assessment(Baseline and 12 weeks post intervention session 12)